148 related articles for article (PubMed ID: 922745)
1. Disordered nocturnal prolactin regulation in women with breast cancer.
Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
[TBL] [Abstract][Full Text] [Related]
3. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and breast skin temperature rhythms in postmenopausal women with primary breast cancer.
Wilson DW; Phillips MJ; Holliday HW; Blamey RW; Simpson HW; Pierrepoint CG; Halberg F; Griffiths K
Chronobiologia; 1983; 10(1):21-30. PubMed ID: 6851763
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
7. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
8. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
10. Importance of serum prolactin determination in metastatic breast cancer patients.
Mujagić Z; Mujagić H
Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
[TBL] [Abstract][Full Text] [Related]
11. Reliability of serum prolactin measurements in women.
Koenig KL; Toniolo P; Bruning PF; Bonfrer JM; Shore RE; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):411-4. PubMed ID: 8220084
[TBL] [Abstract][Full Text] [Related]
12. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
13. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
Lewy H; Haus E; Ashkenazi IE
Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
15. [Correlations between PRL and 17-beta-E in human breast cancer].
Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
[TBL] [Abstract][Full Text] [Related]
16. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
[TBL] [Abstract][Full Text] [Related]
20. Serum prolactin levels in patients with fibrocystic breast disease.
Peters F; Schuth W; Scheurich B; Breckwoldt M
Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
